Cardiac Rhythm Management Devices Market
According to Intent Market Research, the Cardiac Rhythm Management Devices Market is expected to grow from USD 17.6 billion in 2023 at a CAGR of 9.0% to touch USD 32.1 billion by 2030. The Cardiac Rhythm Management Devices Market is dominated by key players such as Medtronic, Boston Scientific Corporation, Abbott Laboratories, Biotronik SE & Co. KG, St. Jude Medical (Now part of Abbott), Philips Healthcare, Stryker Corporation, MicroPort Scientific Corporation, Hoya Corporation, Medico S.p.A., Biotronik, Cook Medical, Zoll Medical Corporation, LivaNova PLC, Edwards Lifesciences Corporation.